Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.34 |
| ▸ | TUBB | P07437 | 1/20 | 0.34 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.34 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.34 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.34 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.34 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.34 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.34 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.34 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.34 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.34 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.34 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20149459 | 0.96 | KDM4E (0.46) | KDM4EATML3MBTL1DUSP3POLB | |
| SCHEMBL20149440 | 0.94 | DUSP3 (0.40) | KDM4EL3MBTL1DUSP3POLBALDH1A1 | |
| SCHEMBL20149465 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1DUSP3POLB | |
| SCHEMBL19769481 | 0.89 | KDM4E (0.42) | KDM4EATML3MBTL1ALDH1A1TDP1 | |
| SCHEMBL20149466 | 0.89 | KDM4E (0.46) | KDM4EATML3MBTL1DUSP3POLB | |
| SCHEMBL20821707 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1DUSP3ALDH1A1 | |
| SCHEMBL25940838 | 0.88 | L3MBTL1 (0.40) | KDM4EATML3MBTL1DUSP3POLB | |
| SCHEMBL20149453 | 0.88 | L3MBTL1 (0.40) | KDM4EATML3MBTL1DUSP3ALDH1A1 | |
| SCHEMBL19319910 | 0.88 | KDM4E (0.45) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL20149433 | 0.87 | L3MBTL1 (0.53) | KDM4EATML3MBTL1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230023388-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220173326-A1 | MELT MIXTURE FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | EML4, LAGE3, KCNN4 | KDM4E 846/4885ATM 4565/4885L3MBTL1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.